<DOC>
	<DOCNO>NCT01295346</DOCNO>
	<brief_summary>The purpose study assess putative brain injury biomarkers utility blood-based traumatic brain injury ( TBI ) diagnostic monitoring tool . This accomplish examine relationship potential serum-based TBI biomarkers clinical measure injury severity , occurrence complication , outcome , subject mild moderate TBI . The assay evaluate sample population subject age 18 refer health care provider close head injury evaluation .</brief_summary>
	<brief_title>Biomarkers Mild Moderate Traumatic Brain Injury</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<criteria>1 . At least 18 year age 80 year age . 2 . Closed injury head within 4 hour symptom onset . 3 . Glasgow Coma Scale ( GCS ) Score 915 . 4 . Head Computerized Tomography ( CT ) perform part routine care . 5 . Subject willing undergo Informed Consent process prior enrollment . 6 . Based upon Principal Investigator 's opinion , subject appropriate candidate study . 1 . Participating another clinical study may affect result either study . 2 . Time injury determine . 3 . Head CT do part clinical emergency care . 4 . Primary diagnosis ischemic hemorrhagic infarct . 5 . Not available 35 day followup visit . 6 . Venipuncture feasible . 7 . Blood donation within 1 week screening . 8 . The Subject otherwise determine Investigator medically unsuitable participation study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>